4-aminobenzoic acid-N-mannoside: RN given refers to D-isomer; RN for cpd without isomeric designation not available 4/88 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 174930 |
| MeSH ID | M0155309 |
| Synonym |
|---|
| 4-aminobenzoic acid-n-mannoside sodium salt |
| 4-[[(3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]benzoic acid |
| benzoic acid, 4-(d-mannopyranosylamino)- |
| k-map |
| 72150-99-3 |
| 4-aminobenzoic acid-n-mannoside |
| DTXSID40992874 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " In this article, the toxic effect of CsA on pancreatic islet cells and the preventive effect of K-MAP on CsA-associated islet cell toxicity were investigated." | ( Modulation of prostaglandin metabolism by K-MAP and prevention of toxic effect of cyclosporin on pancreatic islet cells. Babazono, T; Fuchinoue, S; Fujikawa, H; Fujita, S; Hayashi, T; Honda, H; Kawai, T; Nakagawa, Y; Nakajima, I; Teraoka, S, 1989) | 0.28 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.18) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||